129:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056389:0.958557:0.056389:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158619:-0.158619:0.000000:0.000000:0.000000:0.000000:0.242661:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
No significant interactions exist between antiretroviral :@0.090476:0.084931:0.485144:0.084931:0.485144:0.069149:0.090476:0.069149:0.011188:0.009903:0.004490:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004505:0.003024:0.009223:0.005125:0.009827:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.005866:0.004490:0.009827:0.007257:0.003024:0.005866:0.005125:0.004505:0.010311:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.004505:0.010326:0.009223:0.005125:0.003024:0.004551:0.009827:0.005125:0.004551:0.009903:0.008376:0.003024:0.004551:0.010326:0.003024:0.004188
drugs and the drugs for malaria chemoprophylaxis, me-:@0.076189:0.099086:0.480971:0.099086:0.480971:0.083303:0.076189:0.083303:0.010357:0.004551:0.009192:0.010175:0.005866:0.003916:0.010326:0.009223:0.010357:0.003916:0.005125:0.009223:0.009827:0.003916:0.010357:0.004551:0.009192:0.010175:0.005866:0.003916:0.004747:0.009903:0.004551:0.003916:0.014182:0.010326:0.003024:0.010326:0.004551:0.003024:0.010326:0.003931:0.009782:0.009223:0.009827:0.014182:0.009903:0.010311:0.004551:0.009903:0.010311:0.009223:0.008104:0.003024:0.010326:0.007257:0.003024:0.005866:0.004188:0.003916:0.014182:0.009827:0.005020
floquine or doxycycline, but mefloquine and EFV both :@0.076189:0.113241:0.485144:0.113241:0.485144:0.097458:0.076189:0.097458:0.003666:0.003666:0.009903:0.010311:0.009192:0.003024:0.009223:0.009827:0.005851:0.009903:0.004551:0.005851:0.010357:0.009903:0.007257:0.008104:0.009782:0.008104:0.009782:0.003024:0.003024:0.009223:0.009827:0.004188:0.005851:0.010311:0.009192:0.005125:0.005851:0.014182:0.009827:0.003666:0.003666:0.009903:0.010311:0.009192:0.003024:0.009223:0.009827:0.005851:0.010326:0.009223:0.010357:0.005851:0.008104:0.007333:0.010614:0.005851:0.010311:0.009903:0.005125:0.009223:0.004188
share neuropsychiatric side  effects; therefore  doxycy-:@0.076189:0.127395:0.480956:0.127395:0.480956:0.111613:0.076189:0.111613:0.005866:0.009223:0.010326:0.004551:0.009827:0.006773:0.009223:0.009827:0.009192:0.004551:0.009903:0.010311:0.005866:0.008104:0.009782:0.009223:0.003024:0.010326:0.005125:0.004551:0.003024:0.009782:0.006773:0.005866:0.003024:0.010357:0.009827:0.004188:0.002600:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.006773:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.004188:0.002570:0.010357:0.009903:0.007257:0.008104:0.009782:0.008104:0.005020
cline is the  preferred  choice.  Atovaquone-proguanil :@0.076189:0.141550:0.485128:0.141550:0.485128:0.125768:0.076189:0.125768:0.009782:0.003024:0.003024:0.009223:0.009827:0.008890:0.003024:0.005866:0.008890:0.005125:0.009223:0.009827:0.004188:0.004687:0.010311:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.009827:0.010357:0.004188:0.004687:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.004188:0.004188:0.004687:0.011188:0.005125:0.009903:0.008376:0.010326:0.010311:0.009192:0.009903:0.009223:0.009827:0.005020:0.010311:0.004551:0.009903:0.010175:0.009192:0.010326:0.009223:0.003024:0.003024:0.004188
(Malanil ) should be avoided.:@0.076189:0.155705:0.293376:0.155700:0.293376:0.139918:0.076189:0.139922:0.005579:0.013894:0.010326:0.003024:0.010326:0.009223:0.003024:0.003024:0.006564:0.005579:0.004188:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188:0.010311:0.009827:0.004188:0.010326:0.008376:0.009903:0.003024:0.010357:0.009827:0.010357:0.837110
®:@0.134622:0.150402:0.141172:0.150402:0.141172:0.141248:0.134622:0.141248:0.006550
5:@0.293375:0.150402:0.298233:0.150402:0.298233:0.141248:0.293375:0.141248:0.004858
Cryptococcal meningitis :@0.090476:0.169854:0.275609:0.169854:0.275609:0.153356:0.090476:0.153356:0.011642:0.004687:0.008618:0.009827:0.004385:0.009525:0.009525:0.009525:0.009525:0.009525:0.009827:0.003477:0.008240:0.014061:0.009525:0.008920:0.003477:0.008920:0.009827:0.003477:0.004385:0.003477:0.006501:0.004233
– Where possible, a serum :@0.279615:0.169854:0.485144:0.169854:0.485144:0.154072:0.279615:0.154072:0.007408:0.008149:0.014363:0.009071:0.009676:0.004400:0.009676:0.008149:0.010160:0.009752:0.005715:0.005715:0.002873:0.010160:0.002873:0.009676:0.004037:0.008149:0.010175:0.008149:0.005715:0.009676:0.004400:0.009041:0.014182:0.004188
cryptococcal antigen should be done in patients start-:@0.076189:0.184009:0.480956:0.184009:0.480956:0.168226:0.076189:0.168226:0.009631:0.004400:0.007953:0.010160:0.004974:0.009752:0.009631:0.009752:0.009631:0.009631:0.010175:0.002873:0.005760:0.010175:0.009071:0.004974:0.002873:0.010024:0.009676:0.009071:0.005760:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.005760:0.010160:0.009676:0.005760:0.010205:0.009752:0.009071:0.009676:0.005760:0.002873:0.009071:0.005760:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.005760:0.005715:0.004974:0.010175:0.004400:0.004974:0.005020
ing ART with a CD4 count <100 cells/μl, to screen for early :@0.076189:0.198164:0.485144:0.198164:0.485144:0.182381:0.076189:0.182381:0.002873:0.009071:0.010024:0.003568:0.011037:0.009026:0.006290:0.003568:0.012413:0.002873:0.004974:0.009071:0.003568:0.010175:0.003568:0.012141:0.011097:0.008225:0.003568:0.009631:0.009752:0.009041:0.009071:0.004974:0.003568:0.009011:0.008225:0.008225:0.008225:0.003568:0.009631:0.009676:0.002873:0.002873:0.005715:0.006456:0.009071:0.002873:0.004037:0.003568:0.004974:0.009752:0.003568:0.005715:0.009631:0.004400:0.009676:0.009676:0.009071:0.003568:0.004596:0.009752:0.004400:0.003568:0.009676:0.010175:0.004400:0.002873:0.008104:0.004188
cryptococcal disease and to initiate pre-emptive treat-:@0.076189:0.212318:0.480956:0.212318:0.480956:0.196536:0.076189:0.196536:0.009631:0.004400:0.007953:0.010160:0.004974:0.009752:0.009631:0.009752:0.009631:0.009631:0.010175:0.002873:0.005428:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.005428:0.010175:0.009071:0.010205:0.005428:0.004974:0.009752:0.005428:0.002873:0.009071:0.002873:0.004974:0.002873:0.010175:0.004974:0.009676:0.005428:0.010160:0.004400:0.009676:0.004868:0.009676:0.014030:0.010160:0.004974:0.002873:0.008225:0.009676:0.005428:0.004974:0.004400:0.009676:0.010175:0.004974:0.005020
ment if needed. In patients with cryptococcal meningitis, :@0.076189:0.226473:0.485174:0.226473:0.485174:0.210690:0.076189:0.210690:0.014030:0.009676:0.009071:0.004974:0.003402:0.002873:0.004596:0.003402:0.009071:0.009676:0.009676:0.010205:0.009676:0.010205:0.004037:0.003402:0.003266:0.009071:0.003402:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.003402:0.012413:0.002873:0.004974:0.009071:0.003402:0.009631:0.004400:0.007953:0.010160:0.004974:0.009752:0.009631:0.009752:0.009631:0.009631:0.010175:0.002873:0.003402:0.014030:0.009676:0.009071:0.002873:0.009071:0.010024:0.002873:0.004974:0.002873:0.005715:0.004188:0.004188
ART can be started at four to six weeks after antifungal :@0.076189:0.240628:0.485113:0.240628:0.485113:0.224845:0.076189:0.224845:0.011037:0.009026:0.006290:0.005443:0.009631:0.010175:0.009071:0.005443:0.010160:0.009676:0.005443:0.005715:0.004974:0.010175:0.004400:0.004974:0.009676:0.010205:0.005443:0.010175:0.004974:0.005443:0.004596:0.009752:0.009041:0.004400:0.005443:0.004974:0.009752:0.005443:0.005715:0.002873:0.007106:0.005443:0.012413:0.009676:0.009676:0.007439:0.005715:0.005443:0.010175:0.004596:0.004974:0.009676:0.004400:0.005443:0.010175:0.009071:0.004974:0.002873:0.004596:0.009041:0.009071:0.010024:0.010175:0.003024:0.004188
treatment with amphotericin B and fluconazole.:@0.076189:0.254783:0.419935:0.254783:0.419935:0.239000:0.076189:0.239000:0.004974:0.004400:0.009676:0.010175:0.004974:0.014030:0.009676:0.009071:0.004974:0.004037:0.012413:0.002873:0.004974:0.009071:0.004037:0.010175:0.014030:0.010160:0.009071:0.009752:0.004974:0.009676:0.004400:0.002873:0.009631:0.002873:0.009071:0.004037:0.008527:0.004037:0.010175:0.009071:0.010205:0.004037:0.003591:0.003591:0.009041:0.009631:0.009752:0.009071:0.010175:0.006274:0.009752:0.002873:0.009676:0.004188
5,6:@0.419745:0.249478:0.431715:0.249478:0.431715:0.240325:0.419745:0.240325:0.004770:0.002341:0.004858
 :@0.431717:0.254777:0.435905:0.254777:0.435905:0.238994:0.431717:0.238994:0.004188
immune reCOnstitutiOn :@0.076190:0.287678:0.308284:0.287678:0.308284:0.267513:0.076190:0.267513:0.005174:0.016631:0.016631:0.011826:0.013674:0.009609:0.005174:0.010718:0.009609:0.014413:0.015522:0.013674:0.009609:0.007761:0.005174:0.007761:0.011826:0.007761:0.005174:0.015522:0.013674:0.005174
inflAmmAtOry synDrOme:@0.076190:0.304400:0.323437:0.304400:0.323437:0.284235:0.076190:0.284235:0.005174:0.013674:0.008870:0.008131:0.013674:0.016631:0.016631:0.013674:0.007761:0.015522:0.010718:0.011457:0.005174:0.009609:0.011457:0.013674:0.012935:0.010718:0.015522:0.016631:0.009609
The clinical syndromes of Immune reconstitution inflam:@0.076190:0.320329:0.475907:0.320329:0.475907:0.304547:0.076190:0.304547:0.006441:0.009223:0.009827:0.004581:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004596:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.005866:0.004581:0.009903:0.004747:0.004581:0.003417:0.014182:0.014182:0.009192:0.009223:0.009827:0.004581:0.004551:0.009827:0.009782:0.009903:0.009223:0.005866:0.005125:0.003024:0.005125:0.009192:0.005125:0.003024:0.009903:0.009223:0.004566:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182
-:@0.475907:0.320329:0.480927:0.320329:0.480927:0.304547:0.475907:0.304547:0.005020
matory syndrome (IRIs) are of two types. A paradoxical :@0.076190:0.334484:0.485115:0.334484:0.485115:0.318701:0.076190:0.318701:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004385:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004385:0.005579:0.003417:0.009177:0.003417:0.007529:0.005579:0.004400:0.010326:0.004551:0.009827:0.004385:0.009903:0.004747:0.004385:0.005125:0.012564:0.009903:0.004385:0.005125:0.008104:0.010311:0.009827:0.005866:0.004188:0.004385:0.011188:0.004385:0.010311:0.010326:0.004551:0.010326:0.010357:0.009903:0.007257:0.003024:0.009782:0.010326:0.003024:0.004188
IRIs occurs when paradoxical worsening of symptoms or :@0.076190:0.348639:0.485145:0.348639:0.485145:0.332856:0.076190:0.332856:0.003417:0.009177:0.003417:0.007529:0.003598:0.009903:0.009782:0.009782:0.009192:0.004551:0.005866:0.003583:0.012564:0.009223:0.009827:0.009223:0.003583:0.010311:0.010326:0.004551:0.010326:0.010357:0.009903:0.007257:0.003024:0.009782:0.010326:0.003024:0.003598:0.012564:0.009903:0.004551:0.005866:0.009827:0.009223:0.003024:0.009223:0.010175:0.003583:0.009903:0.004747:0.003583:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.003598:0.009903:0.004551:0.004188
new manifestations of a known condition, typically an :@0.076190:0.362794:0.485145:0.362794:0.485145:0.347011:0.076190:0.347011:0.009223:0.009827:0.012564:0.005670:0.014182:0.010326:0.009223:0.003024:0.004747:0.009827:0.005866:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.005685:0.009903:0.004747:0.005670:0.010326:0.005685:0.007590:0.009223:0.009903:0.012564:0.009223:0.005685:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.005670:0.005125:0.008104:0.010311:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.005700:0.010326:0.009223:0.004188
infection, present upon immune recovery. An unmask-:@0.076190:0.376948:0.480942:0.376948:0.480942:0.361166:0.076190:0.361166:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.005458:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.005473:0.009192:0.010311:0.009903:0.009223:0.005458:0.003024:0.014182:0.014182:0.009192:0.009223:0.009827:0.005473:0.004551:0.009827:0.009782:0.009903:0.008376:0.009827:0.004551:0.008104:0.004188:0.005458:0.011188:0.009223:0.005458:0.009192:0.009223:0.014182:0.010326:0.005866:0.007590:0.005020
ing IRIs occurs when diseases not previously suspected, :@0.076190:0.391103:0.485130:0.391103:0.485130:0.375320:0.076190:0.375320:0.003024:0.009223:0.010175:0.004445:0.003417:0.009177:0.003417:0.007529:0.004445:0.009903:0.009782:0.009782:0.009192:0.004551:0.005866:0.004445:0.012564:0.009223:0.009827:0.009223:0.004445:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005866:0.004460:0.009223:0.009903:0.005125:0.004445:0.010311:0.004551:0.009827:0.008376:0.003024:0.009903:0.009192:0.005866:0.003024:0.008104:0.004460:0.005866:0.009192:0.005866:0.010311:0.009827:0.009782:0.005125:0.009827:0.010357:0.004188:0.337091
become apparent  after initiation of ART.  Managing :@0.076190:0.405258:0.485130:0.405258:0.485130:0.389475:0.076190:0.389475:0.010311:0.009827:0.009782:0.009903:0.014182:0.009827:0.008890:0.010326:0.010311:0.010311:0.010326:0.004551:0.009827:0.009223:0.005125:0.004188:0.004687:0.010326:0.004747:0.005125:0.009827:0.004551:0.008890:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.008890:0.009903:0.004747:0.008890:0.011188:0.009177:0.006441:0.004188:0.004188:0.004687:0.013894:0.010326:0.009223:0.010326:0.010175:0.003024:0.009223:0.010175:0.004188
such patients can be difficult. Treatment includes path:@0.076190:0.419412:0.475938:0.419412:0.475938:0.403630:0.076190:0.403630:0.005866:0.009192:0.009782:0.009223:0.004385:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004385:0.009782:0.010326:0.009223:0.004385:0.010311:0.009827:0.004385:0.010357:0.003024:0.004747:0.003681:0.003681:0.009782:0.009192:0.003024:0.005125:0.004188:0.004385:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004369:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005866:0.004385:0.010311:0.010326:0.005125:0.009223
-:@0.475938:0.419412:0.480957:0.419412:0.480957:0.403630:0.475938:0.403630:0.005020
ogen-specific therapy and anti-inflammatory therapies, :@0.076190:0.433567:0.485145:0.433567:0.485145:0.417784:0.076190:0.417784:0.009903:0.010175:0.009827:0.009223:0.005020:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009782:0.004007:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004007:0.010326:0.009223:0.010357:0.004007:0.010326:0.009223:0.005125:0.003024:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004007:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.003024:0.009827:0.005866:0.004188:0.004188
such  as  nonsteroidal  anti-inflammatory  drugs  (NSAIDs) :@0.076190:0.447722:0.485130:0.447722:0.485130:0.431939:0.076190:0.431939:0.005866:0.009192:0.009782:0.009223:0.004188:0.002495:0.010326:0.005866:0.004188:0.002495:0.009223:0.009903:0.009223:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.010326:0.003024:0.004188:0.002495:0.010326:0.009223:0.005125:0.003024:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.002495:0.010357:0.004551:0.009192:0.010175:0.005866:0.004188:0.002495:0.005579:0.011188:0.007529:0.011188:0.003417:0.011249:0.005866:0.005579:0.004188
or corticosteroids.:@0.076190:0.461877:0.205609:0.461877:0.205609:0.446094:0.076190:0.446094:0.009903:0.004551:0.004188:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188
5,6,12:@0.205588:0.456569:0.229878:0.456569:0.229878:0.447415:0.205588:0.447415:0.004858:0.002429:0.004858:0.002429:0.004858:0.004858
referenCes:@0.076190:0.494769:0.182628:0.494769:0.182628:0.474604:0.076190:0.474604:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1.:@0.076190:0.506706:0.085962:0.506706:0.085962:0.494430:0.076190:0.494430:0.006515:0.003257
World Health Organization. HIV/AIDs. Data and statistics. Available :@0.101390:0.506706:0.484213:0.506706:0.484213:0.494430:0.101390:0.494430:0.011289:0.007702:0.003540:0.002352:0.008055:0.003246:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.003257:0.010219:0.003540:0.007914:0.008032:0.007173:0.002352:0.004998:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003246:0.008032:0.002658:0.008255:0.005139:0.008702:0.002658:0.008749:0.005856:0.003257:0.003257:0.008749:0.008032:0.003986:0.008032:0.003257:0.008032:0.007173:0.008055:0.003257:0.005856:0.003986:0.008032:0.003986:0.002352:0.004563:0.003986:0.002352:0.007608:0.004563:0.003257:0.003257:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.003257
at https://www.who.int/hiv/data/en/. Accessed June 2019. :@0.101390:0.517652:0.441045:0.517652:0.441045:0.505377:0.101390:0.505377:0.008032:0.003986:0.003257:0.007173:0.003986:0.003986:0.008020:0.004563:0.003257:0.005139:0.005139:0.009772:0.009772:0.009772:0.003257:0.009772:0.007173:0.007702:0.003257:0.002352:0.007173:0.003986:0.005139:0.007173:0.002352:0.006515:0.005139:0.008055:0.008032:0.003986:0.008032:0.005139:0.007644:0.007173:0.005127:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.005668:0.007150:0.007173:0.007644:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
2.:@0.076190:0.528598:0.085962:0.528598:0.085962:0.516323:0.076190:0.516323:0.006515:0.003257
UNAIDs World AIDs Day Report – Results. 2012. Available at: http://:@0.101390:0.528598:0.480944:0.528598:0.480944:0.516323:0.101390:0.516323:0.007702:0.008702:0.008702:0.002658:0.008749:0.005856:0.003528:0.011289:0.007702:0.003540:0.002352:0.008055:0.003528:0.008702:0.002658:0.008749:0.005856:0.003540:0.008749:0.008032:0.006303:0.003540:0.007138:0.007644:0.008020:0.007702:0.003540:0.003986:0.003528:0.005880:0.003540:0.007138:0.007644:0.004563:0.007150:0.002352:0.003986:0.004563:0.003257:0.003540:0.006515:0.006515:0.006515:0.006515:0.003257:0.003540:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.003540:0.008032:0.003986:0.003257:0.003528:0.007173:0.003986:0.003986:0.008020:0.003257:0.005139:0.005139
www.unaids.org/en/media/unaids/contentassets/documents/epi-:@0.101390:0.539545:0.480861:0.539545:0.480861:0.527269:0.101390:0.527269:0.009807:0.009795:0.009807:0.003281:0.007173:0.007197:0.008067:0.002387:0.008079:0.004598:0.003281:0.007726:0.003563:0.007937:0.005162:0.007667:0.007197:0.005162:0.011065:0.007667:0.008090:0.002387:0.008067:0.005162:0.007173:0.007197:0.008067:0.002387:0.008090:0.004598:0.005162:0.007632:0.007726:0.007197:0.004010:0.007667:0.007197:0.004010:0.008067:0.004598:0.004598:0.007667:0.004010:0.004598:0.005162:0.008090:0.007726:0.007632:0.007173:0.011054:0.007667:0.007197:0.004010:0.004598:0.005174:0.007667:0.008055:0.002387:0.003904
demiology/2012/gr2012/JC2434_WorldAIDsday_results_en.pdf. Ac-:@0.101390:0.550491:0.480956:0.550491:0.480956:0.538216:0.101390:0.538216:0.008055:0.007644:0.011030:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.005139:0.006515:0.006515:0.006515:0.006515:0.005139:0.007914:0.003540:0.006515:0.006515:0.006515:0.006515:0.005139:0.005668:0.009560:0.006515:0.006515:0.006515:0.006515:0.005880:0.011289:0.007702:0.003540:0.002352:0.008055:0.008702:0.002658:0.008749:0.005856:0.008055:0.008032:0.006303:0.005880:0.003540:0.007644:0.004563:0.007150:0.002352:0.003986:0.004563:0.005880:0.007644:0.007173:0.003257:0.008020:0.008055:0.003692:0.003257:0.004198:0.008702:0.007608:0.003904
cessed August 2013.:@0.101390:0.561437:0.216760:0.561437:0.216760:0.549162:0.101390:0.549162:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.008702:0.007150:0.007914:0.007150:0.004563:0.003986:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
3. :@0.076190:0.572384:0.089220:0.572384:0.089220:0.560108:0.076190:0.560108:0.006515:0.003257:0.490086
statistics south Africa. Mid year population estimates 2011. Avail-:@0.101390:0.572384:0.480932:0.572384:0.480932:0.560108:0.101390:0.560108:0.005856:0.003986:0.008032:0.003986:0.002352:0.004563:0.003986:0.002352:0.007608:0.004563:0.004880:0.005856:0.007702:0.007150:0.003986:0.007173:0.004868:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.003257:0.004868:0.010807:0.002352:0.008055:0.004880:0.006303:0.007644:0.008032:0.003540:0.004880:0.008020:0.007702:0.008020:0.007150:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.004880:0.007644:0.004563:0.003986:0.002352:0.011030:0.008032:0.003986:0.007644:0.004563:0.004880:0.006515:0.006515:0.006515:0.006515:0.003257:0.004880:0.008702:0.006515:0.008032:0.002352:0.002352:0.003904
able at:  http://www.statssa.gov.za/publications/p0302/p03022013.:@0.101390:0.583330:0.480932:0.583330:0.480932:0.571055:0.101390:0.571055:0.008032:0.008020:0.002352:0.007644:0.005268:0.008032:0.003986:0.003257:0.003257:0.001999:0.007173:0.003986:0.003986:0.008020:0.003257:0.005139:0.005139:0.009772:0.009772:0.009772:0.003257:0.004563:0.003986:0.008032:0.003986:0.004563:0.004563:0.008032:0.003257:0.007914:0.007702:0.006515:0.003257:0.004998:0.008032:0.005139:0.006961:0.007150:0.008020:0.002352:0.002352:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.005139:0.006961:0.006515:0.006515:0.006515:0.006515:0.005139:0.006961:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
pdf. Accessed August 2013.:@0.101390:0.594277:0.259352:0.594277:0.259352:0.582001:0.101390:0.582001:0.008020:0.008055:0.003692:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.008702:0.007150:0.007914:0.007150:0.004563:0.003986:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
4.:@0.076190:0.605223:0.085962:0.605223:0.085962:0.592948:0.076190:0.592948:0.006515:0.003257
Fanales-Belasio E,:@0.101390:0.605223:0.200368:0.605223:0.200368:0.592948:0.101390:0.592948:0.005703:0.008032:0.007173:0.008032:0.002352:0.007644:0.004563:0.003904:0.006750:0.007644:0.002352:0.008032:0.004563:0.002352:0.007702:0.002622:0.006303:0.003257
 et al.:@0.200368:0.605223:0.230872:0.605223:0.230872:0.592948:0.200368:0.592948:0.002622:0.007644:0.003986:0.002611:0.008032:0.002352:0.003257
 HIV virology and pathogenetic mechanisms :@0.230872:0.605223:0.484213:0.605223:0.484213:0.592948:0.230872:0.592948:0.002622:0.008032:0.002658:0.008255:0.002622:0.006515:0.002352:0.003540:0.007702:0.002352:0.007702:0.007914:0.006303:0.002622:0.008032:0.007173:0.008055:0.002622:0.008020:0.008032:0.003986:0.007173:0.007702:0.007914:0.007644:0.007173:0.007644:0.003986:0.002352:0.007608:0.002611:0.011030:0.007644:0.007608:0.007173:0.008032:0.007173:0.002352:0.004563:0.011030:0.004563:0.003257
of infection: A brief overview. :@0.101390:0.616169:0.270900:0.616169:0.270900:0.603894:0.101390:0.603894:0.007702:0.003692:0.003257:0.002352:0.007173:0.003692:0.007644:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257:0.008702:0.003257:0.008020:0.003540:0.002352:0.007644:0.003692:0.003257:0.007702:0.006515:0.007644:0.003540:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
Ann Ist Super Sanita.:@0.270877:0.616169:0.385800:0.616169:0.385800:0.603894:0.270877:0.603894:0.008702:0.007173:0.007173:0.003257:0.002658:0.004563:0.003986:0.003257:0.005856:0.007150:0.008020:0.007644:0.003540:0.003257:0.005856:0.008032:0.007173:0.002352:0.003986:0.008032:0.003257
 2010;46(1):5-14.:@0.385788:0.616169:0.476546:0.616169:0.476546:0.603894:0.385788:0.603894:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.003904:0.006515:0.006515:0.003257
5.:@0.076190:0.627116:0.085962:0.627116:0.085962:0.614840:0.076190:0.614840:0.006515:0.003257
Meintjes G, Moorhouse MA, Carmona s, :@0.101390:0.627116:0.339151:0.627116:0.339151:0.614840:0.101390:0.614840:0.010807:0.007644:0.002352:0.007173:0.003986:0.002387:0.007644:0.004563:0.004704:0.010254:0.003257:0.004704:0.010807:0.007702:0.007702:0.003540:0.007173:0.007702:0.007150:0.004563:0.007644:0.004692:0.010807:0.008702:0.003257:0.004704:0.009560:0.008032:0.003540:0.011030:0.007702:0.007173:0.008032:0.004704:0.005856:0.003257:0.003257
et al.:@0.340597:0.627116:0.370571:0.627116:0.370571:0.614840:0.340597:0.614840:0.007644:0.003986:0.004704:0.008032:0.002352:0.003257
 Adult antiretroviral:@0.370571:0.627116:0.480967:0.627116:0.480967:0.614840:0.370571:0.614840:0.004704:0.008702:0.008055:0.007150:0.002352:0.003986:0.004704:0.008032:0.007173:0.003986:0.002352:0.003540:0.007644:0.003986:0.003540:0.007702:0.006515:0.002352:0.003540:0.008032:0.002352
therapy guidelines 2017. :@0.101390:0.638062:0.242901:0.638062:0.242901:0.625787:0.101390:0.625787:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003516:0.007914:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.003528:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
Southern African Journal of HIV Medicine.:@0.243172:0.638062:0.480932:0.638062:0.480932:0.625787:0.243172:0.625787:0.005856:0.007702:0.007150:0.003986:0.007173:0.007644:0.003540:0.007173:0.003516:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.007173:0.003516:0.005668:0.007702:0.007150:0.003540:0.007173:0.008032:0.002352:0.003516:0.007702:0.003692:0.003516:0.008032:0.002658:0.008255:0.003528:0.010807:0.007644:0.008055:0.002352:0.007608:0.002352:0.007173:0.007644:0.003257
2017;18(1), a776.https://doi.org/10.4102/sajhivmed.v18i1.776:@0.101390:0.649008:0.442903:0.649008:0.442903:0.636733:0.101390:0.636733:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.003257:0.008032:0.006515:0.006515:0.006515:0.003257:0.007173:0.003986:0.003986:0.008020:0.004563:0.003257:0.005139:0.005139:0.008055:0.007702:0.002352:0.003257:0.007702:0.003540:0.007914:0.005139:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.005139:0.004563:0.008032:0.002387:0.007173:0.002352:0.006515:0.011030:0.007644:0.008055:0.003257:0.006515:0.006515:0.006515:0.002352:0.006515:0.003257:0.006515:0.006515:0.006515
6. :@0.076190:0.659955:0.088984:0.659955:0.088984:0.647679:0.076190:0.647679:0.006397:0.003140:0.375645
Republic of south Africa National Department of Health. 2019 Antiret-:@0.101390:0.659955:0.480967:0.659955:0.480967:0.647679:0.101390:0.647679:0.007020:0.007526:0.007902:0.007032:0.007902:0.002234:0.002234:0.007491:0.002411:0.007585:0.003575:0.002411:0.005739:0.007585:0.007032:0.003869:0.007056:0.002411:0.008584:0.003575:0.003422:0.002234:0.007491:0.007914:0.002411:0.008584:0.007914:0.003869:0.002234:0.007585:0.007056:0.007914:0.002234:0.002411:0.008631:0.007526:0.007902:0.007914:0.003422:0.003869:0.010913:0.007526:0.007056:0.003869:0.002411:0.007585:0.003575:0.002411:0.007914:0.007526:0.007914:0.002234:0.003869:0.007056:0.003140:0.002411:0.006397:0.006397:0.006397:0.006397:0.002411:0.008584:0.007056:0.003869:0.002234:0.003422:0.007526:0.003869:0.003904
roviral treatment clinical guidelines for the management of HIV in:@0.101390:0.670901:0.480979:0.670901:0.480979:0.658626:0.101390:0.658626:0.003422:0.007585:0.006397:0.002234:0.003422:0.007914:0.002234:0.004986:0.003869:0.003422:0.007526:0.007914:0.003869:0.010913:0.007526:0.007056:0.003869:0.004986:0.007491:0.002234:0.002234:0.007056:0.002234:0.007491:0.007914:0.002234:0.004986:0.007796:0.007032:0.002234:0.007937:0.007526:0.002234:0.002234:0.007056:0.007526:0.004445:0.004974:0.003575:0.007585:0.003422:0.004986:0.003869:0.007056:0.007526:0.004986:0.010913:0.007914:0.007056:0.007914:0.007796:0.007526:0.010913:0.007526:0.007056:0.003869:0.004974:0.007585:0.003575:0.004986:0.007914:0.002540:0.008137:0.004974:0.002234:0.007173
adults, pregnancy, adolescents, children, infants and neonates.:@0.101390:0.681847:0.456837:0.681847:0.456837:0.669572:0.101390:0.669572:0.007914:0.007937:0.007032:0.002234:0.003869:0.004445:0.003140:0.003140:0.007902:0.003422:0.007526:0.007796:0.007056:0.007914:0.007056:0.007491:0.006185:0.003140:0.003140:0.007914:0.007937:0.007585:0.002234:0.007526:0.004445:0.007491:0.007526:0.007056:0.003869:0.004445:0.003140:0.003140:0.007491:0.007056:0.002234:0.002234:0.007937:0.003422:0.007526:0.007056:0.003140:0.003140:0.002234:0.007056:0.003575:0.007914:0.007056:0.003869:0.004445:0.003140:0.007914:0.007056:0.007937:0.003140:0.007056:0.007526:0.007585:0.007056:0.007914:0.003869:0.007526:0.004445:0.003257
7.:@0.076190:0.692794:0.085845:0.692794:0.085845:0.680518:0.076190:0.680518:0.006397:0.003257
World Health Organization. December 2018. Updated recommen-:@0.101390:0.692794:0.480979:0.692794:0.480979:0.680518:0.101390:0.680518:0.011171:0.007585:0.003422:0.002234:0.007937:0.004810:0.007914:0.007526:0.007914:0.002234:0.003869:0.007056:0.004810:0.010101:0.003422:0.007796:0.007914:0.007056:0.002234:0.004880:0.007914:0.003869:0.002234:0.007585:0.007056:0.003140:0.004810:0.008631:0.007526:0.007491:0.007526:0.010913:0.007902:0.007526:0.003422:0.004810:0.006397:0.006397:0.006397:0.006397:0.003140:0.004810:0.007585:0.007902:0.007937:0.007914:0.003869:0.007526:0.007937:0.004810:0.003422:0.007526:0.007491:0.007585:0.010913:0.010913:0.007526:0.007056:0.003904
dations on first-line and second-line antiretroviral regimens and post-:@0.101390:0.703740:0.480967:0.703740:0.480967:0.691465:0.101390:0.691465:0.007937:0.007914:0.003869:0.002234:0.007585:0.007056:0.004445:0.003163:0.007585:0.007056:0.003163:0.002805:0.002805:0.003422:0.004445:0.003869:0.003786:0.002234:0.002234:0.007056:0.007526:0.003163:0.007914:0.007056:0.007937:0.003163:0.004445:0.007526:0.007491:0.007585:0.007056:0.007937:0.003786:0.002234:0.002234:0.007056:0.007526:0.003163:0.007914:0.007056:0.003869:0.002234:0.003422:0.007526:0.003869:0.003422:0.007585:0.006397:0.002234:0.003422:0.007914:0.002234:0.003163:0.003422:0.007526:0.007796:0.002234:0.010913:0.007526:0.007056:0.004445:0.003163:0.007914:0.007056:0.007937:0.003163:0.007902:0.007585:0.004445:0.003869:0.003904
exposure  prophylaxis  and  recommendations  on  early  infant  diag-:@0.101390:0.714687:0.480932:0.714687:0.480932:0.702411:0.101390:0.702411:0.007526:0.005527:0.007902:0.007585:0.004445:0.007032:0.003422:0.007526:0.003257:0.001940:0.007902:0.003422:0.007585:0.007902:0.007056:0.006185:0.002234:0.007914:0.005527:0.002234:0.004445:0.003257:0.001940:0.007914:0.007056:0.007937:0.003257:0.001940:0.003422:0.007526:0.007491:0.007585:0.010913:0.010913:0.007526:0.007056:0.007937:0.007914:0.003869:0.002234:0.007585:0.007056:0.004445:0.003257:0.001940:0.007585:0.007056:0.003257:0.001940:0.007526:0.007914:0.003422:0.002234:0.006185:0.003257:0.001940:0.002234:0.007056:0.003575:0.007914:0.007056:0.003869:0.003257:0.001940:0.007937:0.002234:0.007914:0.007796:0.003904
nosis of HIV. supplement to the 2016 consolidated guidelines on the:@0.101390:0.725633:0.480967:0.725633:0.480967:0.713358:0.101390:0.713358:0.007056:0.007585:0.004445:0.002234:0.004445:0.003469:0.007585:0.003575:0.003469:0.007914:0.002540:0.008137:0.003140:0.003469:0.005739:0.007032:0.007902:0.007902:0.002234:0.007526:0.010913:0.007526:0.007056:0.003869:0.003469:0.003869:0.007585:0.003469:0.003869:0.007056:0.007526:0.003469:0.006397:0.006397:0.006397:0.006397:0.003469:0.007491:0.007585:0.007056:0.004445:0.007585:0.002234:0.002234:0.007937:0.007914:0.003869:0.007526:0.007937:0.003469:0.007796:0.007032:0.002234:0.007937:0.007526:0.002234:0.002234:0.007056:0.007526:0.004445:0.003469:0.007585:0.007056:0.003469:0.003869:0.007056:-0.097959
use of antiretroviral drugs for treating and preventing HIV infection.:@0.101390:0.736579:0.471971:0.736579:0.471971:0.724304:0.101390:0.724304:0.007032:0.004445:0.007526:0.003140:0.007585:0.003575:0.003140:0.007914:0.007056:0.003869:0.002234:0.003422:0.007526:0.003869:0.003422:0.007585:0.006397:0.002234:0.003422:0.007914:0.002234:0.003140:0.007937:0.003422:0.007032:0.007796:0.004445:0.003140:0.003575:0.007585:0.003422:0.003140:0.003869:0.003422:0.007526:0.007914:0.003869:0.002234:0.007056:0.007796:0.003140:0.007914:0.007056:0.007937:0.003140:0.007902:0.003422:0.007526:0.006397:0.007526:0.007056:0.003869:0.002234:0.007056:0.007796:0.003140:0.007914:0.002540:0.008137:0.003140:0.002234:0.007056:0.003575:0.007526:0.007491:0.003869:0.002234:0.007585:0.007056:0.003257
8.:@0.076190:0.747526:0.085962:0.747526:0.085962:0.735250:0.076190:0.735250:0.006515:0.003257
Cohen Ms, :@0.101390:0.747526:0.166490:0.747526:0.166490:0.735250:0.101390:0.735250:0.009560:0.007702:0.007173:0.007644:0.007173:0.002669:0.010807:0.005856:0.003257:0.183464
et al.:@0.165913:0.747526:0.193853:0.747526:0.193853:0.735250:0.165913:0.735250:0.007644:0.003986:0.002669:0.008032:0.002352:0.003257
 HpTN 052 study Team. prevention of HIV-1 infection :@0.193853:0.747526:0.484213:0.747526:0.484213:0.735250:0.193853:0.735250:0.002681:0.008032:0.006961:0.005009:0.008702:0.002669:0.006515:0.006515:0.006515:0.002681:0.005856:0.003986:0.007150:0.008055:0.006303:0.002681:0.005009:0.007644:0.008032:0.011030:0.003257:0.002669:0.006961:0.003540:0.007644:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.002669:0.007702:0.003692:0.002669:0.008032:0.002658:0.008255:0.003904:0.006515:0.002681:0.002352:0.007173:0.003692:0.007644:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257
with early antiretroviral therapy. :@0.101390:0.758472:0.284270:0.758472:0.284270:0.746197:0.101390:0.746197:0.009772:0.002352:0.003986:0.007173:0.003257:0.007644:0.008032:0.003540:0.002352:0.006303:0.003257:0.008032:0.007173:0.003986:0.002352:0.003540:0.007644:0.003986:0.003540:0.007702:0.006515:0.002352:0.003540:0.008032:0.002352:0.003257:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257:0.003257
N Engl J Med.:@0.284259:0.758472:0.361905:0.758472:0.361905:0.746197:0.284259:0.746197:0.008702:0.003257:0.006303:0.007173:0.007914:0.002352:0.003257:0.005668:0.003257:0.010807:0.007644:0.008055:0.003257
 2011;365(6):493-505.:@0.361893:0.758472:0.478710:0.758472:0.478710:0.746197:0.361893:0.746197:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
9. :@0.076190:0.769418:0.089220:0.769418:0.089220:0.757143:0.076190:0.757143:0.006515:0.003257:0.232065
schowalter L, Conradie F. Approaches to tenofovir and abacavir:@0.101390:0.769418:0.480932:0.769418:0.480932:0.757143:0.101390:0.757143:0.005856:0.007608:0.007173:0.007702:0.009772:0.008032:0.002352:0.003986:0.007644:0.003540:0.004469:0.005433:0.003257:0.004480:0.009560:0.007702:0.007173:0.003540:0.008032:0.008055:0.002352:0.007644:0.004469:0.005703:0.003257:0.004480:0.008702:0.008020:0.008020:0.003540:0.007702:0.008032:0.007608:0.007173:0.007644:0.004563:0.004469:0.003986:0.007702:0.004469:0.003986:0.007644:0.007173:0.007702:0.003692:0.007702:0.006515:0.002352:0.003540:0.004469:0.008032:0.007173:0.008055:0.004480:0.008032:0.008020:0.008032:0.007608:0.008032:0.006515:0.002352:0.003540
drug shortages in south Africa: A guide for clinicians. :@0.101390:0.780365:0.414433:0.780365:0.414433:0.768089:0.101390:0.768089:0.008055:0.003540:0.007150:0.007914:0.004727:0.004563:0.007173:0.007702:0.003540:0.003986:0.008032:0.007914:0.007644:0.004563:0.004739:0.002352:0.007173:0.004739:0.005856:0.007702:0.007150:0.003986:0.007173:0.004727:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.003257:0.004727:0.008702:0.004739:0.007914:0.007150:0.002352:0.008055:0.007644:0.004739:0.003692:0.007702:0.003540:0.004727:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.002352:0.008032:0.007173:0.004563:0.003257:-0.107484
SAJHIVMED :@0.415915:0.780365:0.484201:0.780365:0.484201:0.768089:0.415915:0.768089:0.005856:0.008702:0.005668:0.008032:0.002658:0.008255:0.010807:0.006303:0.008749:0.003257
2012;13(2):56-7.:@0.101390:0.791311:0.188891:0.791311:0.188891:0.779036:0.101390:0.779036:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.003257
10. John MA, :@0.076190:0.802258:0.158540:0.802258:0.158540:0.789982:0.076190:0.789982:0.006515:0.006515:0.003257:0.008914:0.005668:0.007702:0.007173:0.007173:0.003410:0.010807:0.008702:0.003257:0.119740
et al.:@0.158705:0.802258:0.187398:0.802258:0.187398:0.789982:0.158705:0.789982:0.007644:0.003986:0.003422:0.008032:0.002352:0.003257
 Lamivudine-induced red cell aplasia. :@0.187398:0.802258:0.405849:0.802258:0.405849:0.789982:0.187398:0.789982:0.003422:0.005433:0.008032:0.011030:0.002352:0.006515:0.007150:0.008055:0.002352:0.007173:0.007644:0.003904:0.002352:0.007173:0.008055:0.007150:0.007608:0.007644:0.008055:0.003422:0.003540:0.007644:0.008055:0.003422:0.007608:0.007644:0.002352:0.002352:0.003422:0.008032:0.008020:0.002352:0.008032:0.004563:0.002352:0.008032:0.003257:0.003257
J Med Micro-:@0.406026:0.802258:0.480956:0.802258:0.480956:0.789982:0.406026:0.789982:0.005668:0.003422:0.010807:0.007644:0.008055:0.003422:0.010807:0.002352:0.007608:0.003540:0.007702:0.003904
biol. :@0.101390:0.813204:0.128331:0.813204:0.128331:0.800929:0.101390:0.800929:0.008020:0.002352:0.007702:0.002352:0.003257:0.003257
2008; 57(8):1032-5.:@0.128331:0.813204:0.232118:0.813204:0.232118:0.800929:0.128331:0.800929:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
11. Falutz J. Therapy insight: shape changes and metabolic complica-:@0.076190:0.824150:0.480956:0.824150:0.480956:0.811875:0.076190:0.811875:0.006515:0.006515:0.003257:0.008914:0.005703:0.008032:0.002352:0.007150:0.003986:0.004998:0.003316:0.005668:0.003257:0.003304:0.005009:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003304:0.002352:0.007173:0.004563:0.002352:0.007914:0.007173:0.003986:0.003257:0.003316:0.005856:0.007173:0.008032:0.008020:0.007644:0.003316:0.007608:0.007173:0.008032:0.007173:0.007914:0.007644:0.004563:0.003316:0.008032:0.007173:0.008055:0.003316:0.011030:0.007644:0.003986:0.008032:0.008020:0.007702:0.002352:0.002352:0.007608:0.003316:0.007608:0.007702:0.011030:0.008020:0.002352:0.002352:0.007608:0.008032:-0.230697
tions associated with HIV and highly active antiretroviral therapy.:@0.101390:0.835097:0.480956:0.835097:0.480956:0.822821:0.101390:0.822821:0.003986:0.002352:0.007702:0.007173:0.004563:0.004704:0.008032:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.007644:0.008055:0.004715:0.009772:0.002352:0.003986:0.007173:0.004704:0.008032:0.002658:0.008255:0.004715:0.008032:0.007173:0.008055:0.004704:0.007173:0.002352:0.007914:0.007173:0.002352:0.006303:0.004704:0.008032:0.007608:0.003986:0.002352:0.006515:0.007644:0.004715:0.008032:0.007173:0.003986:0.002352:0.003540:0.007644:0.003986:0.003540:0.007702:0.006515:0.002352:0.003540:0.008032:0.002352:0.004704:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257
Nat Clin Pract Endocrinol Metab. :@0.101390:0.846043:0.291667:0.846043:0.291667:0.833768:0.101390:0.833768:0.008702:0.008032:0.003986:0.003257:0.009560:0.002352:0.002352:0.007173:0.003257:0.006961:0.003540:0.008032:0.007608:0.003986:0.003257:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.003257:0.010807:0.007644:0.003986:0.008032:0.008020:0.003257:0.003257
2007;3(9):651-61.:@0.291643:0.846043:0.385659:0.846043:0.385659:0.833768:0.291643:0.833768:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
12. Armstrong WS. The immune reconstitution inflammatory syndrome: :@0.076190:0.856989:0.484225:0.856989:0.484225:0.844714:0.076190:0.844714:0.006515:0.006515:0.003257:0.008914:0.008702:0.003540:0.011030:0.004563:0.003986:0.003540:0.007702:0.007173:0.007914:0.003951:0.011289:0.005856:0.003257:0.003963:0.005009:0.007173:0.007644:0.003963:0.002352:0.011030:0.011030:0.007150:0.007173:0.007644:0.003963:0.003540:0.007644:0.007608:0.007702:0.007173:0.004563:0.003986:0.002352:0.003986:0.007150:0.003986:0.002352:0.007702:0.007173:0.003951:0.002352:0.007173:0.002852:0.002852:0.008032:0.011030:0.011030:0.008032:0.003986:0.007702:0.003540:0.006303:0.003963:0.004563:0.006303:0.007173:0.008055:0.003540:0.007702:0.011030:0.007644:0.003257:-0.277617
A clinical update. :@0.101390:0.867936:0.205836:0.867936:0.205836:0.855660:0.101390:0.855660:0.008702:0.003257:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003257:0.007150:0.008020:0.008055:0.008032:0.003986:0.007644:0.003257:0.003257
Curr Infect Dis Rep. :@0.205836:0.867936:0.317137:0.867936:0.317137:0.855660:0.205836:0.855660:0.009560:0.007150:0.003540:0.003540:0.003257:0.002658:0.007173:0.003692:0.007644:0.007608:0.003986:0.003257:0.008749:0.002352:0.004563:0.003257:0.007138:0.007644:0.008020:0.003257:0.003257
2013;15(1):39-45.:@0.317126:0.867936:0.411141:0.867936:0.411141:0.855660:0.317126:0.855660:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
13. Jones M, Núñez M. Liver toxicity of antiretroviral drugs. :@0.076190:0.878882:0.416374:0.878882:0.416374:0.866607:0.076190:0.866607:0.006515:0.006515:0.003257:0.008914:0.005668:0.007702:0.007173:0.007644:0.004563:0.004139:0.010807:0.003257:0.004139:0.008702:0.007150:0.007173:0.007644:0.004998:0.004139:0.010807:0.003257:0.004151:0.005433:0.002352:0.006515:0.007644:0.003540:0.004151:0.003986:0.007702:0.005644:0.002352:0.007608:0.002352:0.003986:0.006303:0.004151:0.007702:0.003692:0.004139:0.008032:0.007173:0.003986:0.002352:0.003540:0.007644:0.003986:0.003540:0.007702:0.006515:0.002352:0.003540:0.008032:0.002352:0.004139:0.008055:0.003540:0.007150:0.007914:0.004563:0.003257:-0.238435
Semin Liver:@0.417267:0.878882:0.480956:0.878882:0.480956:0.866607:0.417267:0.866607:0.005856:0.007644:0.011030:0.002352:0.007173:0.004151:0.005433:0.002352:0.006515:0.007644:0.003540
Dis. :@0.101390:0.889828:0.123568:0.889828:0.123568:0.877553:0.101390:0.877553:0.008749:0.002352:0.004563:0.003257:0.003257
2012; 32(2):167-76.:@0.123568:0.889828:0.227356:0.889828:0.227356:0.877553:0.123568:0.877553:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
14.  scherzer R, :@0.076190:0.900775:0.166831:0.900775:0.166831:0.888499:0.076190:0.888499:0.006515:0.006515:0.003257:0.003257:0.005656:0.005856:0.007608:0.007173:0.007644:0.003540:0.004998:0.007644:0.003540:0.003786:0.007138:0.003257:-0.017561
et al.:@0.167372:0.900775:0.196440:0.900775:0.196440:0.888499:0.167372:0.888499:0.007644:0.003986:0.003798:0.008032:0.002352:0.003257
 Association of tenofovir exposure with kidney dis-:@0.196440:0.900775:0.480944:0.900775:0.480944:0.888499:0.196440:0.888499:0.003798:0.008702:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003798:0.007702:0.003692:0.003798:0.003986:0.007644:0.007173:0.007702:0.003692:0.007702:0.006515:0.002352:0.003540:0.003786:0.007644:0.005644:0.008020:0.007702:0.004563:0.007150:0.003540:0.007644:0.003798:0.009772:0.002352:0.003986:0.007173:0.003798:0.005903:0.002352:0.008055:0.007173:0.007644:0.006303:0.003798:0.008055:0.002352:0.004563:0.003904
ease risk in HIV infection. :@0.101390:0.911721:0.243325:0.911721:0.243325:0.899446:0.101390:0.899446:0.007644:0.008032:0.004563:0.007644:0.003257:0.003540:0.002352:0.004563:0.005903:0.003257:0.002352:0.007173:0.003257:0.008032:0.002658:0.008255:0.003257:0.002352:0.007173:0.003692:0.007644:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
AIDS.:@0.243313:0.911721:0.272535:0.911721:0.272535:0.899446:0.243313:0.899446:0.008702:0.002658:0.008749:0.005856:0.003257
 2012;26(7):867-75. :@0.272535:0.911721:0.379579:0.911721:0.379579:0.899446:0.272535:0.899446:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003257
15. Kranick  sM,  Nath  A.  Neurologic  complications of HIV-1 infection:@0.076190:0.922668:0.480956:0.922668:0.480956:0.910392:0.076190:0.910392:0.006515:0.006515:0.003257:0.008914:0.006950:0.003540:0.008032:0.007173:0.002352:0.007608:0.005903:0.003257:0.002328:0.005856:0.010807:0.003257:0.003257:0.002328:0.008702:0.008032:0.003986:0.007173:0.003257:0.002317:0.008702:0.003257:0.003257:0.002317:0.008702:0.007644:0.007150:0.003540:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.003257:0.002317:0.007608:0.007702:0.011030:0.008020:0.002352:0.002352:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.005586:0.007702:0.003692:0.005586:0.008032:0.002658:0.008255:0.003904:0.006515:0.005586:0.002352:0.007173:0.003692:0.007644:0.007608:0.003986:0.002352:0.007702:-0.356439
and its treatment  in the  era of antiretroviral therapy. :@0.101390:0.933614:0.415668:0.933614:0.415668:0.921339:0.101390:0.921339:0.008032:0.007173:0.008055:0.005280:0.002352:0.003986:0.004563:0.005280:0.003986:0.003540:0.007632:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.002011:0.002352:0.007173:0.005280:0.003986:0.007173:0.007644:0.003257:0.002011:0.007644:0.003540:0.008032:0.005280:0.007702:0.003692:0.005280:0.008032:0.007173:0.003986:0.002352:0.003540:0.007644:0.003986:0.003540:0.007702:0.006515:0.002352:0.003540:0.008032:0.002352:0.005280:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257:0.003257
Continuum:@0.417679:0.933614:0.480956:0.933614:0.480956:0.921339:0.417679:0.921339:0.009560:0.007702:0.007173:0.003986:0.002352:0.007173:0.007150:0.007150:0.011030
 :@0.480944:0.933614:0.484201:0.933614:0.484201:0.921339:0.480944:0.921339:0.003257
(Minneap Minn):@0.101379:0.944560:0.192019:0.944560:0.192019:0.932285:0.101379:0.932285:0.004339:0.010807:0.002352:0.007173:0.007173:0.007644:0.008032:0.008020:0.003257:0.010807:0.002352:0.007173:0.007173:0.004339
. 2012;18 (6 Infectious Disease):1319-37:@0.192019:0.944560:0.410165:0.944560:0.410165:0.932285:0.192019:0.932285:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.004339:0.006515:0.003257:0.002658:0.007173:0.003692:0.007644:0.007608:0.003986:0.002352:0.007702:0.007150:0.004563:0.003257:0.008749:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:-0.314976